These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 12518103)
1. [Dose outside the treatment field for external irradiation with high-energy X-ray reduction of the dose of the remaining testis in postoperative irradiation of seminoma]. Sasaki K Nihon Hoshasen Gijutsu Gakkai Zasshi; 2002 Jun; 58(6):817-25. PubMed ID: 12518103 [TBL] [Abstract][Full Text] [Related]
2. [Verification of the protective effect of a testicular shield in postoperative radiotherapy for seminoma]. Matsumoto Y; Umezu Y; Fujibuchi T; Noguchi Y; Fukunaga J; Kimura T; Hirano N; Hirose T; Sonoda S; Matsumoto R Nihon Hoshasen Gijutsu Gakkai Zasshi; 2014 Sep; 70(9):883-7. PubMed ID: 25242597 [TBL] [Abstract][Full Text] [Related]
3. Data required for testicular dose calculation during radiotherapy of seminoma. Mazonakis M; Kokona G; Varveris H; Damilakis J; Gourtsoyiannis N Med Phys; 2006 Jul; 33(7):2391-5. PubMed ID: 16898441 [TBL] [Abstract][Full Text] [Related]
4. Seminoma of the testis: is scrotal shielding necessary when radiotherapy is limited to the para-aortic nodes? Bieri S; Rouzaud M; Miralbell R Radiother Oncol; 1999 Mar; 50(3):349-53. PubMed ID: 10392822 [TBL] [Abstract][Full Text] [Related]
5. Use of peripheral dose data from uniform dynamic multileaf collimation fields to estimate out-of-field organ dose in patients treated employing sliding window intensity-modulated radiotherapy. Sharma SD; Upreti RR; Deshpande DD Phys Med Biol; 2006 Jun; 51(11):2987-95. PubMed ID: 16723779 [TBL] [Abstract][Full Text] [Related]
6. External beam abdominal radiotherapy in patients with seminoma stage I: field type, testicular dose, and spermatogenesis. Jacobsen KD; Olsen DR; Fosså K; Fosså SD Int J Radiat Oncol Biol Phys; 1997 Apr; 38(1):95-102. PubMed ID: 9212009 [TBL] [Abstract][Full Text] [Related]
7. [Testicular seminoma in stages I and II non-bulky. 16 years' experience]. Maranzano E; Latini P; Leggio M; Aristei C; Panizza BM; Perrucci E; Lupattelli M Radiol Med; 1994 Jun; 87(6):865-9. PubMed ID: 8041942 [TBL] [Abstract][Full Text] [Related]
9. Field-size dependence of doses of therapeutic carbon beams. Kusano Y; Kanai T; Yonai S; Komori M; Ikeda N; Tachikawa Y; Ito A; Uchida H Med Phys; 2007 Oct; 34(10):4016-22. PubMed ID: 17985647 [TBL] [Abstract][Full Text] [Related]
10. Buildup/surface dose and exit dose measurements for a 6-MV linear accelerator. Purdy JA Med Phys; 1986; 13(2):259-62. PubMed ID: 3084928 [TBL] [Abstract][Full Text] [Related]
11. Revisiting fetal dose during radiation therapy: evaluating treatment techniques and a custom shield. Owrangi AM; Roberts DA; Covington EL; Hayman JA; Masi KM; Lee C; Moran JM; Prisciandaro JI J Appl Clin Med Phys; 2016 Sep; 17(5):34-46. PubMed ID: 27685109 [TBL] [Abstract][Full Text] [Related]
12. Scattered radiation to gonads: role of testicular shielding for para-aortic and homolateral illiac nodal radiotherapy. Singhal MK; Kapoor A; Singh D; Bagri PK; Narayan S; Nirban RK; Kumar HS J Egypt Natl Canc Inst; 2014 Jun; 26(2):99-101. PubMed ID: 24841161 [TBL] [Abstract][Full Text] [Related]
13. Radiation therapy for stage IIA and IIB testicular seminoma: peripheral dose calculations and risk assessments. Mazonakis M; Berris T; Lyraraki E; Damilakis J Phys Med Biol; 2015 Mar; 60(6):2375-89. PubMed ID: 25716274 [TBL] [Abstract][Full Text] [Related]
14. Radiation protection measurements around a 12 MeV mobile dedicated IORT accelerator. Soriani A; Felici G; Fantini M; Paolucci M; Borla O; Evangelisti G; Benassi M; Strigari L Med Phys; 2010 Mar; 37(3):995-1003. PubMed ID: 20384235 [TBL] [Abstract][Full Text] [Related]
15. Out-of-field doses and neutron dose equivalents for electron beams from modern Varian and Elekta linear accelerators. Cardenas CE; Nitsch PL; Kudchadker RJ; Howell RM; Kry SF J Appl Clin Med Phys; 2016 Jul; 17(4):442-455. PubMed ID: 27455499 [TBL] [Abstract][Full Text] [Related]
16. Testicular seminoma: Scattered radiation dose to the contralateral testis in the modern era. Lieng H; Chung P; Lam T; Warde P; Craig T Pract Radiat Oncol; 2018; 8(2):e57-e62. PubMed ID: 29306641 [TBL] [Abstract][Full Text] [Related]
17. Protection of testes during radiation treatment by irregular and focused fields of 25 MV x-rays: in vivo evaluation of the absorbed dose. Marcie S; Costa A; Lagrange JL Med Dosim; 1995; 20(4):269-73. PubMed ID: 8703322 [TBL] [Abstract][Full Text] [Related]
18. A reduction in the AAPM TG-36 reported peripheral dose distributions with tertiary multileaf collimation. American Association of Physicists in Medicine Task Group 36. Mutic S; Klein EE Int J Radiat Oncol Biol Phys; 1999 Jul; 44(4):947-53. PubMed ID: 10386654 [TBL] [Abstract][Full Text] [Related]
19. Out-of-field organ doses and associated radiogenic risks from para-aortic radiotherapy for testicular seminoma. Mazonakis M; Berris T; Varveris C; Lyraraki E; Damilakis J Med Phys; 2014 May; 41(5):051702. PubMed ID: 24784368 [TBL] [Abstract][Full Text] [Related]
20. Radiation dose to testes and risk of infertility from radiotherapy for rectal cancer. Mazonakis M; Damilakis J; Varveris H; Gourtsouiannis N Oncol Rep; 2006 Mar; 15(3):729-33. PubMed ID: 16465437 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]